Autori: Perk Stojan
| Naslov | Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial (Article) |
| Autori | Howard James ... Perk Stojan ... (broj koautora 16) |
| Info | LANCET NEUROLOGY, (2021), vol. 20 br. 7, str. 526-536 |
| Projekat | argenx |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
